Global EditionASIA 中文雙語Fran?ais
    World
    Home / World / Europe

    More countries pause vaccine roll-out for fear of potential clot risks

    By JULIAN SHEA in London | China Daily Global | Updated: 2021-03-17 09:30
    Share
    Share - WeChat
    Vials labelled with partially torn sticker "AstraZeneca COVID-19 Coronavirus Vaccine" are seen in front of a displayed EU flag in this illustration taken March 15, 2021. [Photo/Agencies]

    Officials from the United Nations and European Union are to hold talks as the temporary suspension of deployment of the AstraZeneca novel coronavirus vaccine continues to spread across the EU, because of fears that it may be connected to cases of blood clotting.

    Its suspension, said Tedros Adhanom Ghebreyesus, Director General of the World Health Organization, or WHO, "does not necessarily mean these events are linked to vaccination, but it's routine practice to investigate them, and it shows that the surveillance system works and that effective controls are in place".

    At the same time as EU countries are increasingly expressing doubts about the vaccine made by the Anglo-Swedish pharmaceutical company, European Commission President Ursula von der Leyen has announced a deal for what she called the "accelerated delivery" of 10 million doses of the vaccine developed by BioNTech and Pfizer, for the second quarter of the year.

    "This will bring the total deliveries of this vaccine to 200 million doses for that quarter," she tweeted. "It will give (EU) Member States room to manoeuvre and possibly fill gaps in deliveries."

    Germany, France, Portugal and Spain have become the latest countries to join a growing list of countries that have called a temporary halt to use of the vaccine, despite reassurances from the European Medicines Agency, or EMA, that there is no link between the vaccine and a small number of cases of people who developed blood clots after receiving it.

    Germany's Health Minister Jens Spahn said the "precautionary" measure was taken after consultation with national health regulator, the Paul Ehrlich Institute (PEI), adding that "the decision is a professional, not political one" and that any further decision on its use would be made based on new information coming from the EMA.

    "After new reports of thrombroses of the cerebral veins in connection with the vaccination in Germany and Europe, the PEI considers further investigations to be necessary," said a statement from the health ministry. "The most important thing for confidence is transparency," Spahn added.

    French President Emmanuel Macron also announced a temporary halt to its use on Monday. "The decision that was taken, in accordance with our European policy, is to suspend as a precaution the vaccination with AstraZeneca, hoping to resume it as soon as possible if the opinion is favorable," he explained. Macron made the comments at a Franco-Spanish summit, which took place as Spain too stopped using the vaccine for at least a fortnight.

    The WHO said on Monday that its Global Advisory Committee on Vaccine Safety would meet on Tuesday, and has been in close contact with the EMA, which has in turn said it will make an announcement about the AstraZeneca vaccine on Thursday, which it hopes will bring the matter to a conclusion.

    "EMA currently remains of the view that the benefits of the AstraZeneca vaccine in preventing COVID-19, with its associated risk of hospitalization and death, outweigh the risks of side effects," the organization said in a statement.

    Better news for AstraZeneca has come from Australia, where the country's chief medical officer, Paul Kelly, says there is no link between the vaccine and blood clots.

    However, the only vaccine manufacturer in the country, CSL, has said it is in talks with the Australian government about producing alternatives to the AstraZeneca jab.

    "While CSL remains open to discussions about manufacture of alternative COVID-19 vaccines, our resources are fully committed to the manufacture of the AstraZeneca vaccine," the company's chief scientific officer, Andrew Nash, told The Guardian.

    Most Viewed in 24 Hours
    Top
    BACK TO THE TOP
    English
    Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
    License for publishing multimedia online 0108263

    Registration Number: 130349
    FOLLOW US
    久久无码国产专区精品| 色窝窝无码一区二区三区| 日韩精品无码一区二区中文字幕 | 乱人伦中文字幕在线看| 69ZXX少妇内射无码| 亚洲av无码一区二区三区四区| 人妻少妇久久中文字幕| 亚洲AV无码一区二区三区国产 | 国产成人无码AⅤ片在线观看| 国产精品 中文字幕 亚洲 欧美| 精品国产a∨无码一区二区三区| 久久午夜夜伦鲁鲁片免费无码影视| 人妻少妇久久中文字幕一区二区| 亚洲av无码国产精品色在线看不卡| 无码人妻精品一区二区三区夜夜嗨 | 中文亚洲AV片在线观看不卡| 久久精品中文无码资源站| 国产成人无码AV一区二区在线观看 | 无码内射中文字幕岛国片| 中文字幕精品无码一区二区| 久久精品中文字幕一区| 亚洲AV中文无码字幕色三| a中文字幕1区| 中文字幕热久久久久久久| 曰韩无码AV片免费播放不卡| 日韩精品无码久久一区二区三| www无码乱伦| 黑人无码精品又粗又大又长 | 亚洲AV无码乱码国产麻豆| 亚洲日韩精品一区二区三区无码 | 久久精品中文騷妇女内射| 被夫の上司に犯中文字幕| 中文字幕久久精品无码| 精品久久亚洲中文无码| 最近免费中文字幕MV在线视频3 | 色综合久久最新中文字幕| 日韩欧美中文在线| 欧美一级一区二区中文字幕| 狠狠精品久久久无码中文字幕 | 暖暖日本中文视频| 中文字幕日本高清|